JP2014500960A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500960A5
JP2014500960A5 JP2013538809A JP2013538809A JP2014500960A5 JP 2014500960 A5 JP2014500960 A5 JP 2014500960A5 JP 2013538809 A JP2013538809 A JP 2013538809A JP 2013538809 A JP2013538809 A JP 2013538809A JP 2014500960 A5 JP2014500960 A5 JP 2014500960A5
Authority
JP
Japan
Prior art keywords
seq
subject
bin1
level
skeletal muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013538809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014500960A (ja
JP5866126B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059574 external-priority patent/WO2012087437A2/en
Publication of JP2014500960A publication Critical patent/JP2014500960A/ja
Publication of JP2014500960A5 publication Critical patent/JP2014500960A5/ja
Application granted granted Critical
Publication of JP5866126B2 publication Critical patent/JP5866126B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013538809A 2010-11-09 2011-11-07 骨格筋量および神経性状態のマーカーとしてのbin1発現 Active JP5866126B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41168310P 2010-11-09 2010-11-09
US61/411,683 2010-11-09
PCT/US2011/059574 WO2012087437A2 (en) 2010-11-09 2011-11-07 Bin1 expression as a marker of skeletal muscle mass and neurological conditions

Publications (3)

Publication Number Publication Date
JP2014500960A JP2014500960A (ja) 2014-01-16
JP2014500960A5 true JP2014500960A5 (https=) 2014-12-25
JP5866126B2 JP5866126B2 (ja) 2016-02-17

Family

ID=46314702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013538809A Active JP5866126B2 (ja) 2010-11-09 2011-11-07 骨格筋量および神経性状態のマーカーとしてのbin1発現

Country Status (6)

Country Link
US (1) US9891232B2 (https=)
EP (1) EP2638403B1 (https=)
JP (1) JP5866126B2 (https=)
AU (2) AU2011345312A1 (https=)
CA (1) CA2817519C (https=)
WO (1) WO2012087437A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120094300A1 (en) 2009-04-24 2012-04-19 Robin Shaw Bin1 as a Prognostic Marker in Cardiovascular Disease
JP5890840B2 (ja) * 2010-10-20 2016-03-22 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓健康状態のマーカーとしての体液bin1
US9846159B2 (en) 2011-09-30 2017-12-19 Sarcotein Diagnostics, Llc BIN1 expression as a marker of cancer
JP6742330B2 (ja) 2015-03-02 2020-08-19 サーコーティン ダイアグノスティックス エルエルシー 心臓障害のマーカーとしての13+/17+bin1発現
JP6539511B2 (ja) * 2015-06-17 2019-07-03 花王株式会社 運動機能の判定用マーカー
JP6886241B2 (ja) * 2016-01-07 2021-06-16 味の素株式会社 骨格筋面積の評価方法
CA3022515A1 (en) * 2016-05-02 2017-11-09 Prothena Biosciences Limited Antibodies recognizing tau
CN112770723B (zh) * 2018-07-25 2024-08-02 阿克罗斯生物科学公司 Cldn 18.2特异性单克隆抗体及其使用方法
CA3115077A1 (en) * 2018-10-09 2020-04-16 Ibex Biosciences, Llc Antibodies directed to filamin-a and therapeutic uses thereof
US20240026034A1 (en) * 2020-12-15 2024-01-25 Arizona Board Of Regents On Behalf Of Arizona State University Antibodies specific for qsox1 and methods of using the same
CN112794900B (zh) * 2020-12-31 2022-10-25 中南大学湘雅二医院 cBIN1抗体及其应用
CN112778414B (zh) * 2020-12-31 2022-04-15 中南大学湘雅二医院 cBIN1抗体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048702A (en) * 1995-05-05 2000-04-11 The Wistar Institute Of Anatomy And Biology Murine and human box-dependent myc-interacting protein (Bin1) and uses therefor
CA2378982A1 (en) * 1999-07-07 2001-01-18 Regeneron Pharmaceuticals, Inc. Methods of inhibiting muscle atrophy
US6831063B1 (en) * 1999-08-31 2004-12-14 The Wistar Institute Of Anatomy And Biology Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses therefor
WO2005037230A2 (en) * 2003-10-14 2005-04-28 The Trustees Of Columbia University In The City Of New York Compositions and methods for treating heart failure
CA2578680C (en) 2004-04-15 2011-06-14 University Of Florida Research Foundation, Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
WO2006009629A2 (en) * 2004-06-10 2006-01-26 New York University Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same
WO2008008846A2 (en) * 2006-07-11 2008-01-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Differential expression of molecules associated with intra-cerebral hemorrhage
US20120094300A1 (en) * 2009-04-24 2012-04-19 Robin Shaw Bin1 as a Prognostic Marker in Cardiovascular Disease
JP5890840B2 (ja) * 2010-10-20 2016-03-22 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓健康状態のマーカーとしての体液bin1

Similar Documents

Publication Publication Date Title
JP2014500960A5 (https=)
Samsudin et al. Clinical utility and measurement of procalcitonin
JP2013060443A5 (https=)
JP2023002583A (ja) Il23経路バイオマーカーを使用するil23アンタゴニストに対する臨床応答の予測
JP5524990B2 (ja) pLDHに特異的に結合するDNAアプタマー、マラリア診断用組成物およびマラリア診断キット
JP2013500941A5 (https=)
JP2012115275A5 (https=)
JP2016026303A5 (https=)
JP2010115195A5 (https=)
EA201490384A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
JP2012012402A5 (https=)
JP2012526530A5 (https=)
WO2009116861A3 (en) Diagnostic of pre-symptomatic metabolic syndrome
JP2010536043A5 (https=)
JP2014518883A5 (https=)
JP2016029056A5 (https=)
WO2007117444A3 (en) Protein detection by aptamers
JP2016514091A5 (https=)
JP2016136963A5 (https=)
JP2014502848A5 (https=)
JP2013531655A5 (https=)
EA201291314A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
JP2018525333A5 (https=)
JP2012198248A5 (https=)
JP2014503191A5 (https=)